Annual Total Long Term Liabilities
$806.70 K
+$239.30 K+42.17%
01 December 2023
Summary:
Reviva Pharmaceuticals Holdings annual total long term liabilities is currently $806.70 thousand, with the most recent change of +$239.30 thousand (+42.17%) on 01 December 2023. During the last 3 years, it has fallen by -$1.16 million (-58.92%). RVPH annual total long term liabilities is now -58.92% below its all-time high of $1.96 million, reached on 31 December 2020.RVPH Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$77.90 K
-$72.30 K-48.14%
01 September 2024
Summary:
Reviva Pharmaceuticals Holdings quarterly total long term liabilities is currently $77.90 thousand, with the most recent change of -$72.30 thousand (-48.14%) on 01 September 2024. Over the past year, it has dropped by -$728.80 thousand (-90.34%). RVPH quarterly long term liabilities is now -98.14% below its all-time high of $4.19 million, reached on 01 November 2020.RVPH Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RVPH Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -90.3% |
| 3 y3 years | -58.9% | -88.0% |
| 5 y5 years | - | - |
RVPH Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -58.9% | +116.5% | -92.3% | at low |
| 5 y | 5 years | -58.9% | -98.1% | at low | |
| alltime | all time | -58.9% | -98.1% | at low |
Reviva Pharmaceuticals Holdings Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $77.90 K(-48.1%) |
| June 2024 | - | $150.20 K(-57.1%) |
| Mar 2024 | - | $350.50 K(-56.6%) |
| Dec 2023 | $806.70 K(+42.2%) | $806.70 K(-7.6%) |
| Sept 2023 | - | $873.40 K(-13.7%) |
| June 2023 | - | $1.01 M(+82.0%) |
| Mar 2023 | - | $556.30 K(-2.0%) |
| Dec 2022 | $567.40 K | $567.40 K(+436.8%) |
| Sept 2022 | - | $105.70 K(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | $105.70 K(-62.7%) |
| Mar 2022 | - | $283.70 K(-23.9%) |
| Dec 2021 | $372.70 K(-81.0%) | $372.70 K(-42.7%) |
| Sept 2021 | - | $650.90 K(-23.5%) |
| June 2021 | - | $851.20 K(-18.2%) |
| Mar 2021 | - | $1.04 M(-47.0%) |
| Dec 2020 | $1.96 M(>+9900.0%) | $1.96 M(-53.1%) |
| Nov 2020 | - | $4.19 M |
| Dec 2019 | $0.00 | - |
FAQ
- What is Reviva Pharmaceuticals Holdings annual total long term liabilities?
- What is the all time high annual total long term liabilities for Reviva Pharmaceuticals Holdings?
- What is Reviva Pharmaceuticals Holdings quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Reviva Pharmaceuticals Holdings?
- What is Reviva Pharmaceuticals Holdings quarterly long term liabilities year-on-year change?
What is Reviva Pharmaceuticals Holdings annual total long term liabilities?
The current annual total long term liabilities of RVPH is $806.70 K
What is the all time high annual total long term liabilities for Reviva Pharmaceuticals Holdings?
Reviva Pharmaceuticals Holdings all-time high annual total long term liabilities is $1.96 M
What is Reviva Pharmaceuticals Holdings quarterly total long term liabilities?
The current quarterly long term liabilities of RVPH is $77.90 K
What is the all time high quarterly long term liabilities for Reviva Pharmaceuticals Holdings?
Reviva Pharmaceuticals Holdings all-time high quarterly total long term liabilities is $4.19 M
What is Reviva Pharmaceuticals Holdings quarterly long term liabilities year-on-year change?
Over the past year, RVPH quarterly total long term liabilities has changed by -$728.80 K (-90.34%)